Investment for Growth: Now is the time to go big

Born from our universities and research institutes, these companies power innovation, create jobs and attract international investment. But regional disparities and funding gaps are holding back their full potential.

Our new report explores how targeted investment and national collaboration can unlock a new era of growth—one that supports the UK’s ambition to be a life science superpower.

What’s Inside the Report

Spinouts drive innovation
They make up the foundation of science clusters like Cambridge and Oxford—where 80–90% of lab and office take-up now comes from science and tech companies.

Geography matters
More than half of UK life science spinouts are born outside the Oxford-Cambridge-London “Golden Triangle,” but receive just 28% of venture capital investment.

Global competition is rising
6% of UK spinouts have already moved abroad in search of stronger ecosystems and better access to capital.

Space and funding are critical
The availability of quality lab space and access to funding—especially at later stages—can determine whether spinouts stay, scale, or leave.